Merck CEO Kenneth Frazier is sticking around. The New Jersey-based pharmaceutical giant said Wednesday that its board of directors had overturned a policy requiring CEOs to retire when they turn ...
Frazier stepped down as Merck CEO in February 2021 after nearly 30 years at the pharma group, including 10 years in the top job during which time he is credited with overseeing the fast ...
During an hour-long, wide-ranging interview with the Economic Club of New York, Frazier, the CEO of New Jersey-based pharma giant Merck, addressed the issue of rising prescription drug costs and ...
Merck CEO Robert Davis joins 'Squawk Box' to discuss the company's quarterly earnings results, which topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has ranked No. 1 on Newsweek’s annual list of America’s Most Responsible Companies for the second year in a row.